pld
Showing 1 - 8 of 8
Gastric Cancer Trial in Shanghai (PLD, Oxaliplatin, Capecitabine)
Recruiting
- Gastric Cancer
- PLD
- +3 more
-
Shanghai, ChinaShanghai General Hospital
Sep 7, 2022
Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation Trial in Canada, Netherlands, United States (Adavosertib, Paclitaxel,
Active, not recruiting
- Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation
- Adavosertib
- +4 more
-
Gilbert, Arizona
- +19 more
Aug 23, 2022
Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)
Recruiting
- Solid Tumor
- +11 more
- TRK-950
- +14 more
-
Scottsdale, Arizona
- +13 more
Oct 2, 2022
Early Breast Cancer Trial in Shanghai (PLD, CTX, Docetaxel)
Unknown status
- Early Breast Cancer
- PLD
- +4 more
-
Shanghai, ChinaFudan University affiliated cancer hospital
May 13, 2019
Recurrent Platinum-sensitive Ovarian Cancer Trial in Worldwide (Carboplatin, PLD, Bevacizumab)
Completed
- Recurrent Platinum-sensitive Ovarian Cancer
- Carboplatin
- +2 more
-
Bankstown, Australia
- +192 more
Jul 8, 2021
Poorly Differentiated Thyroid Carcinoma Trial in Zhejiang (PLD, Cisplatin)
Unknown status
- Poorly Differentiated Thyroid Carcinoma
- PLD
- Cisplatin
-
Zhejiang, ChinaZhejiang Cancer Hospital
Jan 2, 2018